BioSpace News Archive

Business

Jnana Therapeutics Announces Promotion of Joel Barrish, Ph.D., to President and Chief Scientific Officer

Jnana Therapeutics today announced the promotion of Joel Barrish, Ph.D., a co-founder of the company, to President and Chief Scientific Officer from his previous role as Chief Scientific Officer.

November 2, 2021
·
3 min read
Business

Concert Pharmaceuticals to Report Third Quarter 2021 Results on November 9, 2021

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its financial results for the third quarter of 2021, on Tuesday, November 9, 2021, before the U.S. financial markets open.

November 2, 2021
·
1 min read
Business

Catalent, Inc. Reports First Quarter Fiscal 2022 Results

Catalent, Inc. today announced financial results for the first quarter of fiscal 2022, which ended September 30, 2021.

November 2, 2021
·
24 min read
BioCapital

Valted Seq Raises $10.5 Million in Seed Funding Round

Valted Seq, a biotechnology company focused on the genetic elucidation of neurodegenerative disease pathways to accelerate development of new therapeutics and diagnostics, announced the completion of a seed fundraising round totaling $10.5 million.

November 2, 2021
·
2 min read
Business

ADC Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates

ZYNLONTA ® (loncastuximab tesirine-lpyl) third quarter 2021 net sales of $13.1 million

November 2, 2021
·
19 min read
Pharm Country

Bruker Announces Major Advances in CCS-Enabled 4D Proteomics at ASMS

Bruker PaSER™ software now incorporates transformative CCS-enabled DIA-NN deep neural network learning with breakthrough dia-PASEF capabilities to identify

November 2, 2021
·
8 min read
Cybin Hosting Research and Development Briefing on November 8, 2021

Cybin Inc. will host an in-person and virtual research and development (“R&D”) briefing releasing positive research findings and data on Monday, November 8, 2021 from 8:30 am to 9:30 am (EST)

November 2, 2021
·
6 min read
Business

Moderna and Metagenomi Establish Collaboration to Develop Next-Generation In Vivo Gene Editing Therapeutics

Moderna and Metagenomi Establish Collaboration to Develop Next-Generation In Vivo Gene Editing Therapeutics

November 2, 2021
·
6 min read
Business

Pieris Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Company To Host an Investor Conference Call on Tuesday, November 2, 2021 at 8:00 AM EDT

November 2, 2021
·
11 min read
Business

Acorda Third Quarter 2021 Update: Webcast Scheduled for November 9, 2021

Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a Webcast in conjunction with its third quarter 2021 update and financial results on Tuesday, November 9, at 4:30 p.m. ET.

November 2, 2021
·
4 min read